Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 14;38(6):BSR20181501.
doi: 10.1042/BSR20181501. Print 2018 Dec 21.

Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway

Affiliations

Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway

Bin Liu et al. Biosci Rep. .

Abstract

Osteosarcoma (OS) is the most common primary malignancy of skeleton with higher mortality rates amongst children and young adults worldwide, whereas effective and secure therapies have also been sought by researches with ongoing efforts. The purpose of the present study was to investigate the impact of N'-[(3Z)-1-(1-hexyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene] benzohydrazide (MDA19) on OS and explore its potential mechanism. Cell Counting Kit-8 (CCK8) and colony formation assay were employed to evaluate the potential effect of MDA19 on U2OS and MG-63 cells proliferation. Moreover, transwell migration and invasion assay were performed to assess the influence of MDA19 on U2OS and MG-63 cells migration and invasion. In addition, Annexin V-FITC/propidium iodide (Annexin V-FITC/PI) staining and flow cytometry were used to examine apoptotic ratio of the U2OS and MG-63 cells. Meanwhile, Western blot analysis was applied to explore change of relevant mechanism proteins in OS cells treated with MDA19. Our study showed that MDA19 had anti-proliferative activity of OS cells in a dose- and time-dependent manner, simultaneously, inhibition of colony formation was also observed in U2OS and MG-63 cells after incubation of MDA19. Besides, MDA19 could significantly inhibit the number of migrated and invaded OS cells and markedly increase the OS cells apoptosis rate. Mechanistically, we detected detectable reductions in apoptosis related proteins, epithelial-mesenchymal transition (EMT)-related proteins and activity of phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling in U2OS and MG-63 cells exposure to MDA19. Overall, the current study indicates in vitro anti-proliferative, anti-metastatic, and pro-apoptotic potential of MDA19 in U2OS and MG-63 cells. Our findings propose a clue for further studies with this compound in preclinical and clinical treatment for OS.

Keywords: EMT; MDA19; Osteosarcoma; PI3K/Akt/mTOR signaling.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests associated with the manuscript.

Figures

Figure 1
Figure 1. The potential activity of MDA19 on OS cells proliferation
(A) Effect of MDA19 on U2OS and MG-63 cells’ viability after incubation at MDA19 concentrations 0–200 µM was detected by CCK8 assay. (B) Effect of MDA19 on U2OS and MG-63 cells’ viability after incubation at 0–72 h of MDA19. (C) Colony formation test was executed to examine U2OS and MG-63 cells proliferation after treatment with MDA19. Values are presented as mean ± S.D. **P<0.01 compared with NC groups.
Figure 2
Figure 2. The impact of invasive and migratory capacities in OS cells treated with MDA19 was detected by transwell invasion and migration assay
(A) The change of invaded U2OS and MG-63 cells number after incubation of MDA19. (B) The change of migrated U2OS and MG-63 cells number after incubation of MDA19. All data are presented as mean ± S.D. **P<0.01 compared with NC groups.
Figure 3
Figure 3. The effect of apoptosis in OS cells administrated with MDA19 was tested by flow cytometry after Annexin V-FITC/PI staining and Western blot assay
(A) The change of apoptotic rate in U2OS and MG-63 cells after incubation of MDA19. (B) Western blot analysis was performed to test a series of antibodies (Bcl-2, Bax, Cleaved Caspase-3, and Gapdh). All values are expressed as mean ± S.D. **P<0.01 compared with NC groups.
Figure 4
Figure 4. The potency of EMT in OS cells treated with MDA19 was tested by Western blot assay
(A) Western blots analyze changes of EMT-related proteins in OS cells and proteins bands were quantitated. (B) Densitometric quantitation of protein bands were measured by QUANTITY ONE software. All values are expressed as mean ± S.D. **P<0.01 compared with NC groups.
Figure 5
Figure 5. The activity of PI3K/Akt pathway was examined in OS cells exposure to MDA19
(A and C) Western blots analyze changes of PI3K/Akt pathway-related proteins in OS cells and proteins bands were quantitated. (B and D) Densitometric quantitation of protein bands were measured by QUANTITY ONE software. All values are expressed as mean ± S.D. **P<0.01 compared with NC groups.

Similar articles

Cited by

References

    1. Lindsey B.A., Markel J.E. and Kleinerman E.S. (2017) Osteosarcoma overview. Rheumatol. Ther. 4, 25–43 10.1007/s40744-016-0050-2 - DOI - PMC - PubMed
    1. Jawad M.U., Cheung M.C., Clarke J., Koniaris L.G. and Scully S.P. (2011) Osteosarcoma: improvement in survival limited to high-grade patients only. J. Cancer Res. Clin. Oncol. 137, 597–607 10.1007/s00432-010-0923-7 - DOI - PMC - PubMed
    1. Bielack S.S., Hecker-Nolting S., Blattmann C. and Kager L. (2016) Advances in the management of osteosarcoma. F1000Res 5, 2767 10.12688/f1000research.9465.1 - DOI - PMC - PubMed
    1. Durfee R.A., Mohammed M. and Luu H.H. (2016) Review of osteosarcoma and current management. Rheumatol Ther. 3, 221–243 10.1007/s40744-016-0046-y - DOI - PMC - PubMed
    1. Posthumadeboer J., Witlox M.A., Kaspers G. J.L. and Van R.B.J. (2011) Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature. Clin. Exp. Metastasis 28, 493–503 10.1007/s10585-011-9384-x - DOI - PMC - PubMed

MeSH terms

Substances